Siegfried Zaiss

This inventor holds 25 USPTO granted patents, primarily in Heterocyclic Chemistry. Top assignees: Bayer Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1993-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siegfried Zaiss. Retrieved from https://idiyas.com/inventor/siegfried-zaiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25

% Patents Active = 96.0

Average Co-Inventor Count = 10.1

ph-index = 8

Forward Citations = 216(Granted Patents)

Company Filing History:

24 out of 12,268

Bayer Aktiengesellschaft

patents

1 out of 192

Bayer Schering Pharma Ag

patents

Years Active: 1993-2010

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Substituted Pyridines

Biphenyl Derivatives

Indole Derivatives

Dihydropyridines

Phenylacetic Acid

Carboxylic Acids

Imidazolidinediones

Pyridones

Phenylglycinamides

Cyclohexane

Trisubstituted Compounds

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7776922 - Substituted [(phenylethanoyl)amino]benzamides (2010-08-17),

2. 5935983 - Use of phenylcyclohexylcarboxamides (1999-08-10),

3. 5863930 - Trisubstituted biphenyls (1999-01-26),

4. 5834481 - Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid (1998-11-10),

5. 5712296 - Substituted pyridines and 2-oxo-1,2-dihydropyridines (1998-01-27),

6. 5708003 - Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid (1998-01-13),

7. 5607962 - Substituted indole derivatives (1997-03-04),

8. 5599823 - Substituted biphenylpyridones (1997-02-04),

9. 5596006 - Trisubstituted biphenyls (1997-01-21),

10. 5594010 - Substituted monopyridylmethyl derivatives (1997-01-14),

11. 5576342 - Phenylglycinamides of heterocyclically substitued phenylacetic acid (1996-11-19),

12. 5559139 - Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and its (1996-09-24),

13. 5530016 - Substituted 2,4-imidazolidinediones (1996-06-25),

14. 5527809 - Substituted imidazo[4,5-b]pyridines and benzimidazoles (1996-06-18),

15. 5492923 - Substituted pyridines and 2-oxo-1,2-dihydropyridines (1996-02-20),

Title: The Innovative Contributions of Siegfried Zaiss

Introduction

Siegfried Zaiss, hailing from Wuppertal, Germany, is a distinguished inventor recognized for his impressive portfolio of 25 patents. His work primarily focuses on medicinal compounds, contributing significantly to the field of pharmaceuticals. His patents exemplify the intersection of innovation and healthcare, addressing various medical challenges and advancing treatment options for patients.

Latest Patents

Among Zaiss's most recent innovations are his patents concerning substituted [(phenylethanoyl)amino]benzamides. This invention details the preparation methods and applications of these compounds in creating medicaments for the treatment and prevention of diseases, particularly inflammatory disorders such as skin conditions, respiratory issues, and cardiovascular diseases like arteriosclerosis and coronary heart disease. Another notable patent involves the use of phenylcyclohexylcarboxamides, which are identified as suitable active ingredients in medications aimed at treating restenosis, a common complication in cardiovascular interventions.

Career Highlights

Zaiss has had a remarkable career, marked by his associations with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Schering Pharma AG. His contributions in these organizations have played a crucial role in advancing medicinal chemistry and therapeutic methodologies.

Collaborations

Throughout his career, Siegfried Zaiss has worked alongside esteemed colleagues, including Martin Beuck and Stefan Wohlfeil. Their collaborative efforts have not only spurred the development of innovative therapeutic solutions but have also fostered a spirit of teamwork essential in the research and development of groundbreaking medications.

Conclusion

Siegfried Zaiss stands out as a key figure in the field of pharmaceutical innovation, with a wealth of patents to his name that demonstrate his commitment to improving healthcare outcomes. His ongoing work continues to inspire future generations of inventors and researchers dedicated to the betterment of medical treatments and patient care.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]